Narlaprevir-impurities | Pharmaffiliates

Narlaprevir

Narlaprevir (trade name Arlansa, codenamed SCH 900518), is an inhibitor of NS3/4A serine protease, intended for the treatment of chronic hepatitis C caused by genotype 1 virus in combination with other antiviral drugs. Reference standards of Narlaprevir API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Narlaprevir - API Standards 
    [catalogue_number] => PA 14 1440000
    [category_ids] => ,78,70,82,76,77,
    [chemical_name] => 
    [weight] => 707.97
    [form] => C36H61N5O7S
    [cas] => 865466-24-6
    [pslug] => 865466-24-6-narlaprevir-api-pa141440000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 14 1440000

Narlaprevir - API Standards


  • Catalogue No.:PA 14 1440000

  • CAS :

    865466-24-6

  • Molecular Formula : C36H61N5O7S

  • Molecular Weight : 707.97